Found 2 resultsAuthor [ Title] Type Year
Filters: Author is Saber, W [Clear All Filters]
Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care In Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome*. Biol Blood Marrow Transplant, 20, 1566-1572. presented at the 10/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24972249. (2014).
Myelodysplastic Syndromes in the United States: An Update for Clinicians. Ann Med, 46, 283-289. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24716735. (2014).